{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:25:53Z","timestamp":1793683553465,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2014035"],"award-info":[{"award-number":["2014035"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jpainsymman.2026.08.006","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:34Z","timestamp":1786981234000},"page":"e524-e531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Frequency, Rationale, and Doses for Opioid Switching in Advanced Cancer: A Longitudinal Cohort Study"],"prefix":"10.1016","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6507-1219","authenticated-orcid":false,"given":"Aaron K.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-4319","authenticated-orcid":false,"given":"Adarsh","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-4864","authenticated-orcid":false,"given":"Brian","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-0645","authenticated-orcid":false,"given":"Jennifer","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpainsymman.2026.08.006_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15030591","article-title":"Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis","volume":"15","author":"Snijders","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.jpainsymman.2026.08.006_bib0002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.jpainsymman.2026.08.006_bib0003","doi-asserted-by":"crossref","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0004","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2015.12.011","article-title":"Opioid switching in cancer pain: from the beginning to nowadays","volume":"99","author":"Mercadante","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10.1016\/j.jpainsymman.2026.08.006_bib0005","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11864-023-01117-9","article-title":"Opioid-induced neurotoxicity in patients with cancer pain","volume":"24","author":"Mercadante","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"9","key":"10.1016\/j.jpainsymman.2026.08.006_bib0006","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G","article-title":"Opioid rotation for cancer pain: rationale and clinical aspects","volume":"86","author":"Mercadante","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.08.006_bib0007","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jpainsymman.2015.02.029","article-title":"Methods of rotation from another strong opioid to methadone for the management of cancer pain: a systematic review of the available evidence","volume":"50","author":"McLean","year":"2015","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.08.006_bib0008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/jpm.2023.0541","article-title":"Opioid switch dosing in chronic cancer pain: a prospective longitudinal study","volume":"27","author":"Wong","year":"2024","journal-title":"J Palliat Med"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.08.006_bib0009","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00520-025-09286-z","article-title":"Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline","volume":"33","author":"Davis","year":"2025","journal-title":"Supportive Care in Cancer"},{"issue":"14","key":"10.1016\/j.jpainsymman.2026.08.006_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15143676","article-title":"Effectiveness of opioid switching in advanced cancer pain: a prospective observational cohort study","volume":"15","author":"Wong","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.jpainsymman.2026.08.006_bib0011","article-title":"Opioids for cancer pain - an overview of Cochrane reviews","volume":"7","author":"Wiffen","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.08.006_bib0012","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","article-title":"Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC","volume":"13","author":"Caraceni","year":"2012","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jpainsymman.2026.08.006_bib0013","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","article-title":"European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review","volume":"25","author":"Dale","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0014","series-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","year":"2019"},{"issue":"6","key":"10.1016\/j.jpainsymman.2026.08.006_bib0015","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/annonc\/mdw097","article-title":"Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV \u2018real life' trial on the variability of response to opioids","volume":"27","author":"Corli","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0016","doi-asserted-by":"crossref","DOI":"10.21037\/apm-22-1296","article-title":"Does cancer type and adjuvant analgesic prescribing influence opioid dose?-a retrospective cross-sectional study","author":"Wong","year":"2023","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/spcare-2024-005028","article-title":"Opioid initiation timing and palliative care referrals in advanced cancer: retrospective study","author":"Wong","year":"2024","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0018","unstructured":"Australian and New Zealand College of Anaesthetists. Opioid dose equivalence calculation table 2021. https:\/\/fpm.anzca.edu.au\/documents\/opioid-dose-equivalence.pdf."},{"issue":"13","key":"10.1016\/j.jpainsymman.2026.08.006_bib0019","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s40265-022-01780-6","article-title":"Cancer pain treatment strategies in patients with Cancer","volume":"82","author":"Mercadante","year":"2022","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.jpainsymman.2026.08.006_bib0020","first-page":"2321","article-title":"Opioid switching and variability in response in pain cancer patients","volume":"27","author":"Corli","year":"2019","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.jpainsymman.2026.08.006_bib0021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpainsymman.2013.08.010","article-title":"Factors associated with survival after opioid rotation in cancer patients presenting to an Outpatient supportive care center","volume":"48","author":"Reddy","year":"2014","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.08.006_bib0022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1533-2500.2009.00335.x","article-title":"Opioid rotation in the management of chronic pain: where is the evidence?","volume":"10","author":"Vissers","year":"2010","journal-title":"Pain Practice"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.08.006_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1071\/AH18184","article-title":"Patterns of health service utilisation among the Australian population with cancer compared with the general population","volume":"44","author":"Ng","year":"2019","journal-title":"Aust Health Rev"},{"issue":"4","key":"10.1016\/j.jpainsymman.2026.08.006_bib0024","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41416-022-01828-0","article-title":"Intensity of care in cancer patients in the last year of life: a retrospective data linkage study","volume":"127","author":"Luta","year":"2022","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.08.006_bib0025","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5694\/mja2.52365","article-title":"Who is bearing the brunt of the increasing cost of cancer care?","volume":"221","author":"Williams","year":"2024","journal-title":"Med J Aust"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0027","series-title":"Information about supply of oral opioid products","year":"2025"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0028","unstructured":"Palliative Care Australia. mediarelease\/ongoing-pain-medicine-shortages-risk-quality-of-life-for-all-australians. https:\/\/palliativecare.org.au\/mediarelease\/ongoing-pain-medicine-shortages-risks-quality-of-life-for-all-australians. accessed 5 February 2026."},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/spcare-2024-005279","article-title":"Challenges with cancer pain management: novel opioid shortages and cancer trials restrictions","author":"Wong","year":"2025","journal-title":"BMJ Support Palliat Care"},{"issue":"5","key":"10.1016\/j.jpainsymman.2026.08.006_bib0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/0269216310392102","article-title":"Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project","volume":"25","author":"Caraceni","year":"2011","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0031","article-title":"Update of the Australian Guideline for the management of cancer pain in adults","author":"Lovell","year":"2025","journal-title":"Asia-Pacific J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jpainsymman.2026.08.006_bib0032","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0032","article-title":"Adult Cancer Pain, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology","volume":"23","author":"Swarm","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0033","article-title":"Effect of gene variants on opioid dose, pain and adverse effect outcomes in advanced cancer: an explorative study","author":"Wong","year":"2023","journal-title":"Pharmacogenomics"},{"issue":"14\u201315","key":"10.1016\/j.jpainsymman.2026.08.006_bib0034","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14622416.2024.2430161","article-title":"Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer?","volume":"25","author":"Wong","year":"2024","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1089\/jpm.2024.0112","article-title":"Influence of COMT (rs4680) and OPRM1 (rs1799971) on cancer pain, opioid dose, and adverse effects","author":"Wong","year":"2024","journal-title":"J Palliat Med"},{"issue":"4","key":"10.1016\/j.jpainsymman.2026.08.006_bib0036","first-page":"301","article-title":"Breakthrough cancer pain management (BTcP)\u2014Gap analysis of the current Australian landscape","volume":"34","author":"Lee","year":"2026","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.jpainsymman.2026.08.006_bib0037","first-page":"135","article-title":"Opioid rotation in cancer pain treatment","volume":"115","author":"Schuster","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"9","key":"10.1016\/j.jpainsymman.2026.08.006_bib0038","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1177\/02692163251362563","article-title":"Oxycodone\/naloxone PR versus oxycodone PR in advanced cancer: a multi-centre randomised trial (ENhANCE trial)","volume":"39","author":"Wong","year":"2025","journal-title":"Palliat Med"},{"issue":"1","key":"10.1016\/j.jpainsymman.2026.08.006_bib0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ajco.13561","article-title":"Oxycodone\/naloxone prolonged-release tablets in patients with moderate-to-severe, chronic cancer pain: challenges in the context of hepatic impairment","volume":"18","author":"Le","year":"2022","journal-title":"Asia Pac J Clin Oncol"},{"issue":"5","key":"10.1016\/j.jpainsymman.2026.08.006_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14050483","article-title":"Managing severe cancer pain with oxycodone\/naloxone treatment: a literature review update","volume":"14","author":"Formenti","year":"2024","journal-title":"J Pers Med"},{"issue":"8","key":"10.1016\/j.jpainsymman.2026.08.006_bib0041","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1000678","article-title":"Early palliative care for patients with metastatic non-small-cell lung cancer","volume":"363","author":"Temel","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2026.08.006_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102470","article-title":"Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trial","volume":"74","author":"Adenis","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"4","key":"10.1016\/j.jpainsymman.2026.08.006_bib0043","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.21037\/tlcr.2019.12.18","article-title":"Earlier multidisciplinary palliative care intervention for people with lung cancer: a systematic review and meta-analysis","volume":"9","author":"Kochovska","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.jpainsymman.2026.08.006_bib0044","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_100038","article-title":"Why and how to integrate early palliative care into cutting-edge personalized cancer care","volume":"44","author":"Petrillo","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600953X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088539242600953X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:03:40Z","timestamp":1792839820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088539242600953X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S088539242600953X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.08.006","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency, Rationale, and Doses for Opioid Switching in Advanced Cancer: A Longitudinal Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Inc. on behalf of American Academy of Hospice and Palliative Medicine.","name":"copyright","label":"Copyright"}]}}